Epsilogen Ltd – Trademark Portfolio
Entity Type: 99
Epsilogen Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IGEG and EPSILOGEN. The owner is based in London.
2 Royal College Street
The London Bioscience Innovation Centre
London NW10NH , GB
Showing of trademarks Trademarks
Trademark Classifications
Epsilogen Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Epsilogen Ltd have?
Epsilogen Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Epsilogen Ltd file in?
Epsilogen Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Epsilogen Ltd's most well-known trademarks?
Epsilogen Ltd's registered trademark portfolio includes well-known marks such as IGEG and EPSILOGEN. These are among 2 currently registered trademarks in the portfolio.
What is Epsilogen Ltd's trademark registration success rate?
Epsilogen Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.